FIELD: medicine.
SUBSTANCE: invention relates to a method of treating a bacterial infection in a patient, including administering to a patient in need of such treatment a therapeutically effective amount of ethyl 3-(((((2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl)oxy)sulfonyl)oxy)-2,2-dimethylpropanoate or a pharmaceutically acceptable salt thereof and a therapeutically effective amount of a β-lactam antibiotic, wherein the bacteria causing the bacterial infection produce β-lactamase and whereβ-lactam antibiotic is ceftibuten.
EFFECT: development of a treatment method based on a new compound or its pharmaceutically acceptable salt and β-lactam antibiotic, which can be used in medicine to effectively treat bacterial infections.
1 cl, 79 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BETA-LACTAMASE INHIBITORS AND APPLICATION THEREOF | 2018 |
|
RU2753401C2 |
| ORALLY ADMINISTERED COMBINATIONS OF BETA-LACTAM ANTIBIOTICS AND AVIBACTAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2020 |
|
RU2825281C1 |
| BETA-LACTAMASE INHIBITORS | 2009 |
|
RU2445314C9 |
| (2S,5R)-5-[(BENZYLOXY)AMINO]PIPERIDINE-2-CARBOXAMIDE | 2012 |
|
RU2610091C2 |
| METHOD OF PRODUCING HETEROCYCLIC COMPOUNDS, INCLUDING TRANS-7-OXO-6-(SULPHOXY)-1,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXAMIDE AND ITS SALT | 2012 |
|
RU2769076C2 |
| CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND METHOD FOR PRODUCTION THEREOF | 2014 |
|
RU2695219C2 |
| HETEROCYCLIC COMPOUNDS AND USE THEREOF FOR PREVENTING OR TREATING BACTERIAL INFECTIONS | 2016 |
|
RU2715058C2 |
| CRYSTALLINE FORMS OF DIAZABICLOCTANE DERIVATIVE AND A METHOD OF THEIR PRODUCTION | 2014 |
|
RU2801220C2 |
| DERIVATIVES OF 7-OXO-1,6-DIAZABICYCLO[3.2.1]OCT-3-ENE, USEFUL FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2645678C2 |
| METHOD OF PRODUCING A DIAZABICYCLOOCTANE DERIVATIVE AND INTERMEDIATE THEREOF | 2014 |
|
RU2719480C2 |
